The role of GPSM3 in tumor-promoting emergency myelopoiesis
GPSM3在促肿瘤紧急骨髓细胞生成中的作用
基本信息
- 批准号:9449420
- 负责人:
- 金额:$ 36.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-07 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferBone MarrowCCAAT-Enhancer-Binding ProteinsCancer ControlCell Differentiation processCell LineCell physiologyCellsColony-Stimulating FactorsCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentEmergency SituationEventFoundationsGTP-Binding ProteinsGenetic TranscriptionGoalsHematopoieticHumanImmunosuppressionImmunosuppressive AgentsInterleukin-6KnowledgeLinkMalignant NeoplasmsMeasuresMediatingMediator of activation proteinMelanoma CellModelingMolecularMusMyelogenousMyeloid CellsMyeloid-derived suppressor cellsMyelopoiesisOutputPhenotypeRoleSTAT1 geneSTAT3 geneSignal PathwaySignal TransductionSignaling ProteinT-LymphocyteTestingThe Cancer Genome AtlasTissuesTumor ImmunityTumor PromotionTumor-DerivedTumor-associated macrophagesUp-RegulationWorkcytokinegain of functiongranulocyteimmunoregulationloss of functionmelanomamigrationmonocyteneoplastic cellnew therapeutic targetnovelprogenitorrecruitresponseselective expressiontargeted cancer therapytranscription factortumortumor growthtumor microenvironmenttumor progression
项目摘要
Cancer progression is associated with a profound alteration in “emergency” myelopoiesis, leading to
recruitment of mostly immunosuppressive cells such as myeloid-derived suppressor cells (MDSC) and tumor-
associated macrophages (TAM). In response to saturating amounts of tumor-induced colony-stimulating
factors (CSFs), myeloid progenitors divide more frequently to sustain the hematopoietic output necessary
to promote emergency myelopoiesis. Despite the knowledge about the involvement of cytokines and
transcription factors in emergency myelopoiesis, the molecular mechanisms by which the cytokines induce
transcriptional events regulating cancer-driven myelopoiesis remain largely unclear. Our preliminary data show
that G protein signaling modulator-3 (GPSM3) is upregulated selectively in MDSC, either from tumor-
bearing hosts or generated from bone marrow myeloid progenitors by the cytokines G-CSF, GM-CSF and
IL-6. GPSM3-deficient myeloid progenitors display a reduced capacity to differentiate into
granulocytes/monocytes following G-CSF/GM-CSF stimulation. Decreased accumulation of MDSC in
GPSM3-deficient tumor-bearing hosts is linked with an altered expression in the key transcriptional mediators
of myeloid progenitor commitment and differentiation to the granulocytic/monocytic lineage. Moreover, the
immunoregulatory activity of both tumor-induced and cytokine-induced MDSC is dependent on GPSM3.
These results have led to the novel hypothesis that GPSM3 is a master regulator of cancer-associated
myelopoiesis and key driver of the differentiation of MDSCs for both immune suppression and tumor
promotion. In this proposal, we will characterize further the phenotype and function of MDSC in the tumor
microenvironment, and explore the signaling pathways implicated by GPSM3 in regulating MDSC
differentiation and activation using both gain-of-function and loss-of- function approaches.
癌症进展与“紧急”骨髓生成的深刻变化有关,导致
主要是免疫抑制细胞的招募,如髓系来源的抑制细胞(MDSC)和肿瘤-
相关巨噬细胞()。对饱和数量的肿瘤诱导的集落刺激的响应
因子(CSF),髓系祖细胞分裂更频繁,以维持必要的造血输出
促进急诊骨髓再生。尽管有关于细胞因子和
转录因子在急诊骨髓生成中的作用,细胞因子诱导的分子机制
调控癌症驱动的骨髓生成的转录事件在很大程度上仍不清楚。我们的初步数据显示
G蛋白信号调节剂-3(GPSM3)在MDSC中选择性上调,无论是来自肿瘤还是来自于
承载宿主或由骨髓髓系祖细胞通过细胞因子G-CSF、GM-CSF和
IL-6。缺乏GPSM3的髓系祖细胞分化为
G-CSF/GM-CSF刺激后的粒细胞/单核细胞。减少MDSC在体内的积累
GPSM3缺陷的荷瘤宿主与关键转录介质的表达变化有关
髓系祖细胞向粒/单核细胞谱系的承诺和分化。此外,
肿瘤诱导和细胞因子诱导的MDSC的免疫调节活性均依赖于GPSM3。
这些结果导致了一种新的假设,即GPSM3是癌症相关的主调节因子
免疫抑制和肿瘤MDSCs的骨髓生成及其分化的关键因素
升职。在这个方案中,我们将进一步表征肿瘤中多药耐药干细胞的表型和功能。
微环境,并探讨GPSM3调控MDSC的信号通路
使用功能获得和功能丧失两种方法进行分化和激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bin Zhang其他文献
Bin Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bin Zhang', 18)}}的其他基金
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
半胱氨酰白三烯受体对骨髓源性抑制细胞的独特作用
- 批准号:
10398916 - 财政年份:2020
- 资助金额:
$ 36.14万 - 项目类别:
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
半胱氨酰白三烯受体对骨髓源性抑制细胞的独特作用
- 批准号:
10162565 - 财政年份:2020
- 资助金额:
$ 36.14万 - 项目类别:
From epigenome to genome and back: disentangling the relationship between epigenetic modifications and chromatin organization
从表观基因组到基因组并返回:理清表观遗传修饰与染色质组织之间的关系
- 批准号:
10178047 - 财政年份:2019
- 资助金额:
$ 36.14万 - 项目类别:
From epigenome to genome and back: disentangling the relationship between epigenetic modifications and chromatin organization
从表观基因组到基因组并返回:理清表观遗传修饰与染色质组织之间的关系
- 批准号:
10437740 - 财政年份:2019
- 资助金额:
$ 36.14万 - 项目类别:
From epigenome to genome and back: disentangling the relationship between epigenetic modifications and chromatin organization
从表观基因组到基因组并返回:理清表观遗传修饰与染色质组织之间的关系
- 批准号:
10618347 - 财政年份:2019
- 资助金额:
$ 36.14万 - 项目类别:
The role of GPSM3 in tumor-promoting emergency myelopoiesis
GPSM3在促肿瘤紧急骨髓细胞生成中的作用
- 批准号:
10115623 - 财政年份:2017
- 资助金额:
$ 36.14万 - 项目类别:
CD73 and Tumor Immunity-CD73 and CTLA-4 combination Blockade in Ovarian Cancer
CD73 和肿瘤免疫——CD73 和 CTLA-4 联合阻断卵巢癌
- 批准号:
8628468 - 财政年份:2011
- 资助金额:
$ 36.14万 - 项目类别:
相似海外基金
Impact of physical exercise on brain-bone marrow interactions in postmenopausal rats: potential mechanisms preventing menopause-induced hypertension
体育锻炼对绝经后大鼠脑-骨髓相互作用的影响:预防绝经期高血压的潜在机制
- 批准号:
24K20609 - 财政年份:2024
- 资助金额:
$ 36.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy
改造骨髓生态位来控制干细胞调节、转移进化和癌症休眠
- 批准号:
EP/X036049/1 - 财政年份:2024
- 资助金额:
$ 36.14万 - 项目类别:
Research Grant
Understanding the link between bone marrow failure and chronic inflammation through the lens of VEXAS syndrome
从 VEXAS 综合征的角度了解骨髓衰竭与慢性炎症之间的联系
- 批准号:
MR/Y011945/1 - 财政年份:2024
- 资助金额:
$ 36.14万 - 项目类别:
Research Grant
Bone Marrow Adipogenesis in Response to Chemotherapy and Resultant Effect on Bone Metastasis
骨髓脂肪生成对化疗的反应及其对骨转移的影响
- 批准号:
491636 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Miscellaneous Programs
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
- 批准号:
10537391 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
- 批准号:
10761397 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations
选择性放射性核素输送以实现精确的骨髓生态位改变
- 批准号:
10727237 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
保护骨髓生态位的完整性和功能,使老化的造血干细胞恢复活力
- 批准号:
10735925 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Bone marrow-derived myeloid cell dysregulation in malignant progression of glioma
胶质瘤恶性进展中骨髓源性骨髓细胞失调
- 批准号:
10730970 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别: